Treatment Registry
TR-0475 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by ARSYNL Rx · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$256.33

Medication · Tirzepatide HypoSpray (transdermal, needle-free)$256.33

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide HypoSpray (transdermal, needle-free)

Compounded Tirzepatide HypoSpray® Therapy FROM: $256.33 / month

source

Per month$256.33Charged today$256.33
Visit ARSYNL Rx

We earn nothing from this link. ARSYNL Rx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyThe Pharmacy Hub; Chemistry Rx; Vital Rx; Optimal Balance Pharmacy; Center City Pharmacy; Olympia Pharmacy
PrescriberBoth
Cancellation“How do I reorder or cancel? Login to your Arsynl account and reorder or cancel at any time. You will be contacted before your medication is to be refilled and billed to your credit card.”

Not yet checked: states, membership and consult fee.

Recorded from arsynl.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Tirzepatide is sold in two formats: a standard injectable at $233/mo and a needle-free transdermal 'HypoSpray' at $256.33/mo. The HypoSpray's delivery method (a metered transdermal spray) does not match any of the schema's form options (not an injection, oral tablet, or sublingual placement), so it was recorded as not-disclosed with this note. Neither injectable product page states vial vs. pen.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0475
Readings
1

Related records

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). ARSYNL Rx compounded tirzepatide (TR-0475). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0475

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.